Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them! - Wikidata - wikimedia - TriplyDB

Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them!

Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them!

http://www.wikidata.org/entity/Q24792379

about

Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.Perils and pitfalls of reporting sex differences WHO guidelines on fluid resuscitation in children: missing the FEAST data.Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial.Is the current management of severe sepsis and septic shock really evidence based?Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial.Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Challenges and solutions to pre- and post-randomization subgroup analyses.From concepts, theory, and evidence of heterogeneity of treatment effects to methodological approaches: a primer A systematic review and meta-analysis of 130,000 individuals shows smoking does not modify the association of APOE genotype on risk of coronary heart disease Reducing hip fracture risk with risedronate in elderly women with established osteoporosis.A randomized placebo-controlled trial of methotrexate in psoriatic arthritis Methodologic issues in terminating enrollment of a subgroup of patients in a multicenter randomized trial.Maternal education preferences moderate the effects of mandatory employment and education programs on child positive and problem behaviors.Clinical review: molecular mechanisms underlying the role of antithrombin in sepsis.Healthy aging: can clinical trials deliver?Quantifying App Store Dynamics: Longitudinal Tracking of Mental Health Apps.Outcome based subgroup analysis: a neglected concern.Ticagrelor: positive, negative and misunderstood properties as a new antiplatelet agent.Evaluating the impact of treating the optimal subgroup.Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials.The Effect of Elapsed Time from Myocardial Infarction on Mortality and Major Adverse Cardiac and Cerebrovascular Events in ICD Patients.Subgroup analyses of randomized clinical trials in heart failure: facts and numbers.The value of extended glioblastoma resection: Insights from randomized controlled trials.Stroke genome-wide association studies: the large numbers imperative.Subgroup analysis as a source of spurious findings: an illustration using new data on alcohol intake and coronary heart disease.Stress Echocardiography Positivity Predicts Cancer Death.Social value and individual choice: The value of a choice-based decision-making process in a collectively funded health system.Tutorial on statistical considerations on subgroup analysis in confirmatory clinical trials.Interaction trees with censored survival data.Pre-specified vs. post-hoc subgroup analyses: are we wiser before or after a trial has been performed?Implications for paediatric shock management in resource-limited settings: a perspective from the FEAST trial.Reporting clinical research: An example of balancing a simple clinical message with data required to help future research Interleukin-1 beta inhibition with canakinumab and reducing lung cancer-subset analysis of the canakinumab anti-inflammatory thrombosis outcome study trial (CANTOS)

P2860

Q26773290-80A60934-E851-4D97-8CE5-973784FA93E3 Q30411445-057D6764-6D3D-44F2-AC65-EA13AACDF5F3 Q30725143-33509E34-D73E-4188-A400-A23C119E2045 Q30733469-BF637A96-AA0E-42A0-825B-991B569369A4 Q30788622-C3F7B33C-5716-4336-B935-E6CD58F469DD Q33255319-EF01C846-9B8F-4525-8E35-003AA51925EC Q33919074-7E93F90B-9A9B-4E03-9D94-71C663B3312A Q34194929-567B025A-612E-468D-AE08-36459178B6F6 Q34356025-C8366A0F-1B94-4045-8636-2CF9DF0804A7 Q34509675-A993333A-D488-429E-A791-23D179C736B9 Q34513430-00EB65E0-F4C5-49A1-8DED-0C8EC29F6EBA Q34659539-709D7528-3848-4013-8CED-59B48E153A40 Q36096798-FEED1D54-515F-49F9-A2D1-0F96CBD1EF1E Q36309957-ECA11266-BDF6-4EE2-B470-97D7B1FCD8F2 Q36381390-7BB3BC33-F53B-4BF2-945B-7AC977AB7BFD Q36423261-07C435EA-487D-4B82-A081-4546BF3C4D98 Q36918477-41853FCA-0326-41F1-9641-1F49F8DF4481 Q37198536-B43BA6A2-9594-4C9E-B19B-762D65B7AF94 Q37220070-96E8CD32-95EA-4D98-B68E-843C4E4702DF Q38099380-A2767EEA-2125-4C81-8FEC-114AD284A861 Q38797656-A65CABF5-666D-4672-9242-31755229274D Q40032129-714B7C91-2C0C-47BB-9AB4-E1AA55914516 Q40626713-E8CABFAE-94F1-4706-8068-29A06E48803C Q42374627-B469E444-6AC9-4C23-893E-C867521207A9 Q42593191-B74F9F0C-C293-47E8-8FF4-C0F026E00A30 Q42751865-7B8A6539-C405-49A9-8702-EA237FD90419 Q43076386-101F1A42-62C6-430A-AD96-C866D5AA8544 Q47321737-AC6FFFB0-C21A-4834-A3C9-88FD8BAC7CE4 Q47667703-3936929A-BE86-4449-ADAF-294F24E95EDD Q48195140-DA61DA5A-8D85-4713-B92F-D02F22D33A89 Q51897628-D1ECD9D3-07BE-4885-A191-DD343A3B4B6C Q52876090-5AA9BFB3-7A7A-4F93-84CC-E033E626371C Q55344519-9A6BA071-5E68-491F-B6FB-89CF4F2BAA3C Q57809467-A2663887-EC6B-4561-A26F-BF88A17A8BCB Q58128778-6F145235-5C8D-4F5A-B9AD-3A00E0DFF5AB

P2860

Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them!

http://www.wikidata.org/entity/Q24792379

description

2000 nî lūn-bûn

@nan

2000 թուականին հրատարակուած գիտական յօդուած

@hyw

2000 թվականին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them!

@ast

Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them!

@en

Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them!

@nl

type

label

Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them!

@ast

Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them!

@en

Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them!

@nl

prefLabel

Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them!

@ast

Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them!

@en

Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them!

@nl

P1433

Q24792379-EBD26EE3-E3E7-4FF0-B850-515D8B9D301E

P1476

Q24792379-B6BD4DC7-739E-44A5-9117-F198C2E7A450

P2093

Q24792379-8CE716E0-2D3E-45C7-91D4-4AA3FCB98E11

P2860

Q24792379-19B9A315-065A-4141-ADB8-0D5E2BD1C7FC

Q24792379-40983C7B-7CB7-4D61-B8B4-8D7C6D787181

Q24792379-516F30EA-EE70-4186-BC44-3CB259419AAC

Q24792379-891E912C-EE74-4705-B2B6-1E408E61BA2D

Q24792379-9D16C875-0F2B-4B19-B36B-D30CE73547CA

Q24792379-C3BEB732-9531-49EE-AE4B-3154909EAA5B

Q24792379-FAFA991F-AD6F-4158-B134-1EB5ADF47895

P2888

Q24792379-BE49965C-6A21-4075-A4C1-97EEE44DFC53

P304

Q24792379-0AF37DED-C329-4F87-92DB-B6B7DA4C6924

P31

Q24792379-AD5A1F60-4EAC-4032-9A6C-528C64702491

P3181

Q24792379-034FE08B-B9FF-48B7-86A9-90F69C9F6096

P356

Q24792379-E14241F1-B555-4245-BAD3-FF4CAF5F121B

P433

Q24792379-CDC5BE36-BA88-46E1-A662-AE2D9A18002C

P478

Q24792379-DB0B52B1-83CE-4265-8E6E-0F30D2DE5A0D

P577

Q24792379-E62C63AD-9CC6-4604-B044-49F499DEC7C2

P5875

Q24792379-A8C82AF9-6F8C-4404-B482-A29167B3ACEC

P6179

Q24792379-1F3B71F7-7030-457F-86CE-229809DFBBA7

P698

Q24792379-287F86DB-8938-4CB6-A698-AE17D01B6F6A

P932

Q24792379-E06C224F-84EA-424C-B0AD-FEF183E6872A

P3181

P356

P1433

Current controlled trials in cardiovascular medicine

P1476

Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them!

@en

P2093

Peter Sleight

http://www.w3.org/2001/XMLSchema#string

P2860

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

Beta blockade during and after myocardial infarction: an overview of the randomized trials.

Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.

Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years.

Streptokinase Is Still the Agent of Choice for Most Patients with Myocardial Infarction.

P2888

P304

25-27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4183513

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/CVM-1-1-025

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2000-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11641706

http://www.w3.org/2001/XMLSchema#string

P6179

1048382365

http://www.w3.org/2001/XMLSchema#string

P698

11714402

http://www.w3.org/2001/XMLSchema#string

P932

59592

http://www.w3.org/2001/XMLSchema#string